Trial
NCT01115244
Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
—
Condition
Dermatitis Herpetiformis
Intervention
Dapsone gel, 5%
Why stopped
poor enrollment and lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-14